New therapy-relevant marker may help identify ER+ breast cancer patients who may bene

[News]

A multi-institutional team led by scientists from the Medical College of Wisconsin Cancer Center has discovered PD-L2 as a therapy-relevant marker to identify patients with estrogen receptor-positive breast cancer who may benefit from new immunotherapies.

More... (https://www.news-medical.net/news/20230126/New-therapy-relevant-marker-may-help-identify-ER2b-breast-cancer-patients-who-may-benefit-from-immunotherapies.aspx)